Finding a new drug that represents hope for diabetics, to prevent complications from the disease and prevent kidney and heart disease and other complications resulting from diabetes.
According to the British newspaper “Daily Mail”, high levels of sugar in diabetes can damage blood vessels in the kidneys, and they also reduce the risk of heart problems.
Experts believe that the tablets will save the cost by avoiding patients entering the hospital, as about 4.4 million Britons suffer from type 2 diabetes, which is caused by high blood sugar, stressing that the tablets should be offered to diabetics daily, which reduces the risk of infection. with life-threatening complications in the kidneys and heart.
High sugar levels in diabetes can damage blood vessels in the kidneys. When this happens, toxins cannot be filtered from the blood, putting pressure on the heart..
The newspaper said that the drug Phenirnon fine renoneFor type 2 diabetics with kidney disease, experts say health chiefs will offer the drug to type 2 diabetics in England and Wales.
The newspaper indicated that a decision is scheduled to be issued regarding the financing of the British Health Service Authority NHS for Phenirnon fine renone Next month, the charities say the approval will benefit up to 1.5 million Britons with diabetes who either have kidney disease or are expected to develop it in the future.
Dr. Graham Lipkin, a Trustee of the Foundation confirmed Kidney Care UK: This drug has the exciting potential to dramatically improve the care of patients with chronic kidney disease due to diabetes, it should be of great benefit to patients and help them avoid the need for more intensive treatments in hospital.
About 4.4 million Britons suffer from type 2 diabetes, a condition that occurs when the level of sugar in the blood is too high – often due to genes, obesity and lack of exercise, the newspaper said, adding that this imbalance can lead to a number of complications, including This damages the blood vessels in the kidneys. This harms the kidneys, but it can also cause the hormone aldosterone to be released. Studies show that excess levels of this hormone can lead to kidney problems – causing irreversible damage – and increase the risk of heart disease..
She added that nearly 40% of people with type 2 diabetes will develop kidney disease at some point.
‘These conditions go hand in hand,’ said Dr Kieran McCafferty, a consultant nephrologist in London. It is very important that we have effective treatments for these patients that can treat both
Medicines capable of inhibiting aldosterone are available in the NHS.
Studies show it’s safer than previous drugs, which means it’s not likely to have any heart complications, in a global trial of more than 5,500 adults with associated kidney disease. with type 2 diabetes Participants took the drug daily, and the results, which were published last year in the Journal of Clinical Infertility, held true New England Journal of Medicine found that those who took phenrenone were about one-fifth less likely to die from kidney failure than patients with type 2 diabetes who did not take the drug..
The trial also found that phenrenone reduced the risk of death or hospitalization due to heart failure by 14% after two and a half years. Researchers believe that the long-term benefit of phenrenone could be greater, and they estimate that taking the tablets every day reduces the risk of kidney failure by up to 40. %, which reduces hospitalizations and deaths.
‘This is a really exciting drug,’ says Dr McCafferty. It’s safe and keeps patients out of hospital. The next step will be to offer the treatment to kidney patients who don’t have diabetes – which means many more Britons could one day benefit..”